ORISSA MIN DEV CO LTD

851.55 -7.78 (-0.91%) Sell

ORISSAMINE continues its fall as more investors loose confidence

13 min read

ORISSA MIN DEV CO LTD delivered lacklustre performance today. It returned -0.91% to close at 851.55. It's recent 5 day performance has been -1.46%, -0.8%, -1.84%, +0.11% and -0.73%.

[Themes containing ORISSAMINE]

ORISSAMINE is currently in a down trend. Over the last three months Buy-and-Hold has been a better strategy (returning +28.53%) for ORISSAMINE's investors than shorting it.

Trend

ORISSAMINE has been underperforming the NIFTY-50 index in recent time, after having outperformed till 1 Nov, 2016. Over the last 3 years and 1 month, ORISSAMINE underperformed the NIFTY-50 index on 62% days.

During the last three months ORISSAMINE delivered losses on 61% days. However, it still managed to end this period in a profit. It's best return during this period (of +20.0%) was on Wednesday, 12 Dec, 2018. While it's worst loss in the same period (of -5.46%) was on Thursday, 15 Nov, 2018. There was initially a bullish trend during this period which started on 30 Oct, 2018 and went on till 9 Nov, 2018. The bullish trend returned +51.78% to investors. This was followed by a bearish trend that started on 22 Nov, 2018 and ended on 30 Nov, 2018. This bearish trend lost -9.32% of investor capital.

On monthly basis, ORISSAMINE delivered losses in more months over the last year, than profits. ORISSAMINE delivered profits less regularly than NIFTY-50 index. ORISSAMINE significantly outperformed NIFTY-50 index in Dec 2018, when it returned +23.68% compared to +6.56% returned by NIFTY-50 index during it's best month in the last one year - Jul 2018. ORISSAMINE had a longer winning streak of losing months than NIFTY-50 index. It went down in 6 straight months (from May 2018 to Oct 2018) during which period it delivered -75.55%.

If all the economists were laid end to end, they'd never reach a conclusion.
-- George Bernard Shaw

ORISSAMINE is becoming less volatile overall. In comparison, the NIFTY-50 index is seeing a fall in volatility. During the last three months, there was a significant surge in ORISSAMINE's volatility from 25 Oct, 2018 to 31 Oct, 2018. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that ORISSAMINE has significant negative skewness in it's return distribution. This indicates that ORISSAMINE is very risky for short-term investment and can significantly underperform for long durations.

NIFTY-50 index has more chance of extreme outcomes than ORISSAMINE. Therefore, NIFTY-50 must receive a lower allocation than ORISSAMINE in your portfolio. NIFTY-50 index usually has shorter drawdown period than ORISSAMINE.

On a general note (since you are interested in ORISSAMINE), three large cap instruments that deserve special mention are TORNTPHARM, BAJFINANCE and BRITANNIA. They have all outperformed the market and must be closely watched for investment opportunities.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter